SCHEMBL16999964

SCHEMBL16999964

COC(=O)C1(F)CCN(Cc2ccccc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 8/20 0.55
ALDH1A1 P00352 4/20 0.52
CYP3A4 P08684 4/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
TSHR P16473 1/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
OPRL1 P41146 1/20 0.50
CHRM2 P08172 1/20 0.50
CHRM3 P20309 1/20 0.50
USP2 O75604 1/20 0.50
MAPK1 P28482 1/20 0.50
POLB P06746 2/20 0.49
MMP1 P03956 1/20 0.49
MMP9 P14780 1/20 0.49
MMP13 P45452 1/20 0.49
ADAM17 P78536 1/20 0.49
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14962728 0.92 CYP2D6 (0.53) CYP2D6ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL14962729 0.92 CYP2D6 (0.53) CYP2D6ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL14677254 0.92 CYP2D6 (0.53) CYP2D6ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL1290759 0.86 CYP3A4 (0.65) CYP2D6ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL3498095 0.84 CYP2D6 (0.56) CYP2D6ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL14081425 0.84 CYP2D6 (0.56) CYP2D6ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL3510474 0.83 CYP2D6 (0.55) CYP2D6ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL6746046 0.82 KDM4E (0.60) CYP2D6ALDH1A1OPRL1POLB
SCHEMBL21287577 0.82 KMT2A (0.57) CYP2D6ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL18203100 0.82 L3MBTL1 (0.63) CYP2D6ALDH1A1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9249098-B2 Derivatives of donepezil CHENG XUEHENG (US) 2016-02-02 US disclosed
US-9249098-B2 Derivatives of donepezil CHENG XUEHENG (US) 2016-02-02 US disclosed
US-20150225343-A1 NOVEL DERIVATIVES OF DONEPEZIL CHENG XUEHENG (US) 2015-08-13 US disclosed
US-20150225343-A1 NOVEL DERIVATIVES OF DONEPEZIL CHENG XUEHENG (US) 2015-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150225343-A1 NOVEL DERIVATIVES OF DONEPEZIL ACHE, BCHE, HNMT CYP2D6 487/4885ALDH1A1 324/4885CYP3A4 533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.